Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer

被引:56
|
作者
Verhage, BAJ
van Houwelingen, K
Ruijter, TEG
Kiemeney, LA
Schalken, JA
机构
[1] Univ Nijmegen, Med Ctr, Dept Epidemiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
关键词
prostate cancer; E-cadherin; promoter; single-nucleotide polymorphism; hereditary;
D O I
10.1002/ijc.10541
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-cadherin plays a major role in intercellular adhesion, cell polarity and tissue architecture. We determined the relative risk of PCa associated with a previously reported C/A SN P at -160 bp relative to the transcription-start site of the E-cadherin gene promoter. Eighty-two PCa patients and 188 controls were genotyped. Genotype and allele frequencies differed significantly among cases and controls. A-allele carriers had a higher relative risk of PCa (OR = 3.6, 95% CI 2.0-6.4) compared to C-only carriers. AC and AA genotypes had an increased risk of PCa (OR = 3.8, 95% CI 2.1-6.8 and OR = 1.7, 95% CI 0.4-6.6, respectively) compared to CC genotypes. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:683 / 685
页数:3
相关论文
共 50 条
  • [31] A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk
    Qi, Xiaofei
    Wang, Yu
    Hou, Jianquan
    Huang, Yuhua
    JOURNAL OF CANCER, 2017, 8 (19): : 4083 - 4086
  • [32] E-Cadherin Downregulation is Mediated by Promoter Methylation in Canine Prostate Cancer
    Fonseca-Alves, Carlos Eduardo
    Kobayashi, Priscila Emiko
    Leis-Filho, Antonio Fernando
    Lainetti, Patricia de Faria
    Grieco, Valeria
    Kuasne, Hellen
    Rogatto, Silvia Regina
    Laufer-Amorim, Renee
    FRONTIERS IN GENETICS, 2019, 10
  • [33] The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men
    Pookot, Deepa
    Li, Long-Cheng
    Tabatabai, Z. Laura
    Tanaka, Yuichiro
    Greene, Kirsten L.
    Dahiya, Rajvir
    JOURNAL OF UROLOGY, 2006, 176 (02): : 793 - 796
  • [35] E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population
    Lu, Yan
    Xu, Yao-Chu
    Shen, Jing
    Yu, Rong-Bin
    Niu, Ju-Yin
    Guo, Jian-Tao
    Hu, Xu
    Shen, Hong-Bing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (01) : 56 - 60
  • [36] The role of E-cadherin expression and E-cadherin gene promoter hypermethylation in gastric carcinoma
    Hamed, Mohamed K. F.
    Fawzy, Gamal
    Hanna, Hanna H.
    EGYPTIAN JOURNAL OF SURGERY, 2019, 38 (02): : 361 - 368
  • [37] The associations of an E-cadherin promoter polymorphism (C-160A) with bladder cancer risk and clinical outcomes
    Lin, Jie
    Wang, Yunfei
    Dinney, Colin P.
    Zhao, Hua
    Grossman, Barton H.
    Wu, Xifeng
    CANCER RESEARCH, 2006, 66 (08)
  • [38] E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer
    Lin, J.
    Dinney, C. P.
    Grossman, H. B.
    Jhamb, M.
    Zhu, Y.
    Spitz, M. R.
    Wu, X.
    CLINICAL GENETICS, 2006, 70 (03) : 240 - 245
  • [39] E-cadherin signaling in prostate cancer
    Chunthapong, J
    Seftor, E
    Khalkhali-Ellis, Z
    Sullivan, CM
    Hendrix, MJC
    Heidger, PM
    FASEB JOURNAL, 2003, 17 (05): : A1175 - A1175
  • [40] Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
    Kiemeney, L.
    van Houwelingen, K.
    Bogaerts, M.
    Witjes, A.
    Swinkels, D.
    den Heijer, M.
    Franke, B.
    Schalken, J.
    Verhaegh, G.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S110 - S110